Back to 
Centiva Capital, LP
Centiva Capital, LP
TGTX
Showing 0 of 2 quarters
Position history for Centiva Capital, LP's holdings in TG THERAPEUTICS INC
No. Centiva Capital exited its TGTX (TG Therapeutics) position in Q3 2020. Its Q2 2020 13F listed 25,654 shares worth $500,000. Centiva Capital first reported TGTX in Q2 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.